- Home
- HDL vs BMEZ Comparison
HDL vs BMEZ Comparison
Compare HDL & BMEZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HDL | BMEZ |
|---|---|---|
| Founded | 2016 | N/A |
| Country | Singapore | United States |
| Employees | 13651 | N/A |
| Industry | Restaurants | Trusts Except Educational Religious and Charitable |
| Sector | Consumer Discretionary | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | 936.9M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | HDL | BMEZ |
|---|---|---|
| Price | $16.46 | $14.18 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 835.0 | ★ 205.8K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $10.47 | N/A |
| Revenue Next Year | $14.04 | N/A |
| P/E Ratio | $55.56 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $15.83 | $12.58 |
| 52 Week High | $28.88 | $15.80 |
Technical Indicators
Market Signals| Indicator | HDL | BMEZ |
|---|---|---|
| Relative Strength Index (RSI) | 47.07 | 29.09 |
| Support Level | $16.08 | $14.07 |
| Resistance Level | $16.99 | $14.29 |
| Average True Range (ATR) | 0.23 | 0.19 |
| MACD | -0.06 | -0.06 |
| Stochastic Oscillator | 20.61 | 3.06 |
Price Performance
Historical ComparisonAbout HDL SUPER HI INTERNATIONAL HOLDING LTD. American Depositary Shares
Super Hi International Holding Ltd is an investment holding company and its subsidiaries are principally engaged in restaurant operations, delivery business, and sales of hot pot condiment products and food ingredients located in the overseas market outside Mainland China, Hong Kong, Macau, and Taiwan. Its mission is to become a world-wide integrated restaurant group, build the world's Chinese cuisine brand, and promote Chinese culinary heritage world-wide.
About BMEZ BlackRock Health Sciences Term Trust of Beneficial Interest
BlackRock Health Sciences Trust II is a closed-ended management investment company. The investment objective is to provide total return through a combination of current income and long-term capital appreciation. The Trust seeks to achieve its investment objective by investing, under normal market conditions, at least 80% of its total assets in equity securities of energy and natural resources companies and equity derivatives with exposure to the energy and natural resources industry.